Manning & Napier Group’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-594,282
Closed -$21.3M 328
2019
Q4
$21.3M Sell
594,282
-238,746
-29% -$8.87M 0.23% 100
2019
Q3
$29.1M Sell
833,028
-238
-0% -$9.15K 0.33% 79
2019
Q2
$35.8M Buy
833,266
+25,135
+3% +$1.04M 0.39% 62
2019
Q1
$34.9M Sell
808,131
-128,074
-14% -$5.15M 0.38% 63
2018
Q4
$34.2M Sell
936,205
-120,469
-11% -$4.47M 0.42% 56
2018
Q3
$42.4M Sell
1,056,674
-31,443
-3% -$1.26M 0.42% 57
2018
Q2
$41.7M Sell
1,088,117
-999,383
-48% -$36.8M 0.41% 55
2018
Q1
$71.5M Sell
2,087,500
-230,625
-10% -$8.1M 0.7% 45
2017
Q4
$76M Buy
+2,318,125
New +$79.9M 0.68% 47

Other funds holding QGEN

Manning & Napier Group's QGEN Position: Q1 2020 in Review

Manning & Napier Group sold out of Qiagen (QGEN) in Q1 2020, closing a stake of 594,282 shares — an estimated $21.3M sold.

Manning & Napier Group first reported a position in QGEN in Q4 2017 and held it in 9 quarters. The position peaked at $76M in Q4 2017. 259 funds tracked by Wall St. Rank hold QGEN as of Q1 2020.

  • Manning & Napier Group reported no remaining Qiagen position as of Q1 2020 after selling out during the quarter.
  • Manning & Napier Group sold 594,282 Qiagen shares in Q1 2020, an estimated $21.3M.
  • Manning & Napier Group first reported a position in Qiagen in Q4 2017 and held it in 9 quarters.
  • Manning & Napier Group's Qiagen position peaked at $76M in Q4 2017.
  • 259 funds tracked by Wall St. Rank held Qiagen as of Q1 2020.

Based on Manning & Napier Group's 13F filing for Q1 2020, filed 13 Apr 2020.